Mahamaya Lifesciences IPO
Introduction
Mahamaya Lifesciences Limited, with over two decades in the agri-chemicals space, is taking a bold leap with its much-awaited SME IPO. Backed by robust manufacturing, a diversified product line, and commitment to farmer productivity, Mahamaya is on a mission to empower Indian agriculture with high-quality crop protection and soil health solutions. Let’s walk through what makes this IPO compelling—and whether it should be on your watchlist.
IPO Highlights
|
Feature |
Details |
|
Issue Size |
₹70.44 crore (Fresh ₹64.28 cr + OFS ₹6.16 cr) |
|
Price Band |
₹108–₹114 per share |
|
Lot Size |
1,200 shares (Min. 2 lots = 2,400 shares) |
|
Min. Investment |
₹2,73,600 (upper band/retail) |
|
IPO Dates |
Nov 11 to Nov 13, 2025 |
|
Allotment |
Nov 14, 2025 |
|
Listing |
Nov 18, 2025 (BSE SME) |
|
Face Value |
₹10 per share |
|
Reservation |
Retail: 33.33%, Others: 66.67% |
Note: Anchor investors contributed ₹19.97 crore; S-HNI at least 3 lots (3,600 shares); B-HNI at least 8 lots (9,600 shares).
What Does Mahamaya Lifesciences Do?
Founded in 2002, Mahamaya Lifesciences is engaged in manufacturing, registration, and export of crop protection products and bioproducts—serving both Indian and global farming communities with insecticides, herbicides, fungicides, bio-stimulants, and biofertilizers. The company’s technical expertise enables new product launches for Indian agriculture and a complementary export business, enhancing productivity and sustainability in crops and soils.
Company Financials :-
Mahamaya Lifesciences Ltd.'s revenue increased by 64% and profit after tax (PAT) rose by 148% between the financial year ending with March 31, 2025 and March 31, 2024.
|
Period Ended |
30 Jun 2025 |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Assets |
218.87 |
188.35 |
112.07 |
77.88 |
|
Total Income |
84.04 |
267.17 |
162.83 |
137.40 |
|
Profit After Tax |
4.10 |
12.94 |
5.22 |
3.75 |
|
EBITDA |
8.04 |
24.64 |
13.36 |
8.91 |
|
NET Worth |
53.50 |
49.42 |
24.66 |
19.44 |
|
Reserves and Surplus |
35.73 |
31.66 |
23.41 |
18.19 |
|
Total Borrowing |
57.72 |
58.11 |
54.63 |
24.37 |
|
Amount in ₹ Crore |
||||
Objectives of the IPO :-
|
S.No. |
Objects of the Issue |
Expected Amount (₹ in crores) |
|
1 |
Purchase of Equipment for existing Formulation plant |
3.75 |
|
2 |
Funding capital expenditure towards setting up of a new technical manufacturing plant |
29.42 |
|
3 |
Construction of Warehouse Building and Purchase of Machinery |
2.53 |
|
4 |
Funding working capital requirement of our Company |
18.00 |
|
5 |
General Corporate purposes |
- |
IPO Reservation :-
|
Investor Category |
Shares Offered |
|
Market Maker Shares Offered |
3,09,600 (5.01%) |
|
QIB Shares Offered |
29,28,000 (47.39%) |
|
NII (HNI) Shares Offered |
8,82,000 (14.27%) |
|
Retail Shares Offered |
20,59,200 (33.33%) |
|
Total Shares Offered |
61,78,800 (100.00%) |
Strengths
- Strong financial growth: Revenues up sharply to ₹267.17 crore in FY25 from ₹162.83 crore in FY24, with sustainable profits
- Diversified, scalable product portfolio: Covering chemical and bioproduct segments for crop and soil health
- Export opportunities: Robust global network, major revenue from international markets
- Track record of manufacturing excellence: Goodwill in Indian agri-inputs market, recognized for quality and reliability
Key Risks
- Customer concentration: 70–83% of sales come from top 10 customers, exposing the business to order volatility and dependency.
- Sector cyclicality: Business is exposed to agricultural cycles, monsoons, and commodity pricing patterns.
- Policy and regulatory risk: Changes in regulations, bans or quality standards could impact operations or product approvals.
- Working capital intensity: Large inventory and receivables, especially with growing exports, could strain balance sheet if not managed.
How To Apply for the IPO ?
- Login or Open demat account with JM Financial Services / JM PRO app: Open the JM PRO app or JM Financial Services website and log in with your credentials.
- Go to Discover section & Locate the IPO Section: Navigate to the 'IPO' section on the platform.
- Select IPO: Find and select the IPO from the list of open IPOs.
- Enter the Lot Size: Specify the number of lots you want to bid for.
- Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
- Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
How To Check the Allotment Status of IPO?
Steps to check IPO allotment status on JM Pro app:
- Log in to the JM Pro app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
JM Financial Services will notify you of your IPO allotment status via push notification and email
Final Thoughts :-
Mahamaya Lifesciences brings a blend of established expertise and growth ambition to India’s SME IPO space. Whether you’re an agro-sector enthusiast or keen on high-growth manufacturing, this is one SME IPO to keep on your radar.
FAQs
Q: What are the Mahamaya Lifesciences IPO dates and price band?
A: Nov 11–13, 2025; price band ₹108–₹114 per share.
Q: What is the minimum investment/lot size?
A: 2,400 shares/2 lots (₹2,73,600 at upper price).
Q: Where will Mahamaya Lifesciences shares be listed?
A: BSE SME platform; listing date is Nov 18, 2025.
Q: What’s the main aim of the IPO?
A: To expand manufacturing, build new capacity, buy equipment, construct warehouses, working capital, and general purposes.
Q: Are there any anchor or HNI quotas?
A: Yes—anchor investors, S-HNIs (min 3 lots), and B-HNIs (min 8 lots).
Q: What are the sector and company risks?
A: High customer dependency, policy risk, cyclicality, working capital intensity, and evolving regulatory environment.
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)
